It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. After-hours trades for Caredx Inc (CDNA) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.39, or -4.03%, to $9.29. The Caredx Inc has recorded 4,649 volume in the after hours trading session. Earlier, Yahoo Finance discussed this stock as it revealed CareDx Reports Third Quarter 2023 Results.
Caredx Inc is listed on the NASDAQ in the Healthcare sector while operating in the Diagnostics & Research industry. The current market capitalization of Caredx Inc is $523.69M. A total of 1.41 million shares were traded on the day, compared to an average of 922.02K shares.
Insider trades are also considered as indicators of how a stock will perform in the future, in addition to stock predictions. During the recent three months, CDNA has seen 4 BUY and 5 SELL insider trades, representing the acquisition of 366,156 and the disposition of 10,902 shares. Over the last 12 months, there were 33 BUYs and 50 SELLs from insiders. Insiders purchased 1,162,686 shares during that period but sold 158,055.
In the most recent transaction, Seeto Reginald sold 2,818 shares of CDNA for 6.91 per share on Oct 02. After the transaction, the insider now owns 479,164 company shares. In a previous transaction on Sep 05, Seeto Reginald sold 2,819 shares at 9.49 per share. CDNA shares that the insider owns now total 481,982.
Among the insiders who sold shares, Seeto Reginald disposed of 576 shares on Aug 14 at a per-share price of $8.89. This resulted in the insider holding 484,801 shares of CDNA after the transaction. In another insider transaction, Seeto Reginald sold 2,819 shares at $11.35 per share on Aug 02. Company shares held by the insider now total 486,051.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. According to analysts who have offered 12-month price targets for CDNA in the last 3 months, the mean price target is $10.80 with high estimates of $13.00 and low estimates of $9.00. In terms of 52-week highs and lows, CDNA has a high of $18.04 and a low of $4.80.
As of this writing, CDNA has an earnings estimate of -$0.28 per share for the current quarter. EPS was calculated based on a consensus of 5 estimates, with a high estimate of -$0.24 per share and a lower estimate of -$0.39. The company reported an EPS of -$0.18 in the last quarter, which was 41.90% higher than expectations of -$0.31.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. CDNA’s latest balance sheet shows that the firm has $348.49M in Cash & Short Term Investments as of fiscal 2021. There were $17.39M in debt and $77.30M in liabilities at the time. Its Book Value Per Share was $7.28, while its Total Shareholder’s Equity was $465.88M.
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CDNA is Buy with a score of 4.00.